Valuation wise, Paradigm Biopharmaceuticals (ASX:PAR) is what Winston Churchill referred to as a riddle wrapped in a mystery ...

LNZ100 is a single-use, once-daily eye drop containing aceclidine, a small molecule acetylcholine receptor agonist that causes miosis.

ADRX-0405 is a novel antibody-drug conjugate targeting STEAP1, and a phase 1a/b study will investigate the agent for the ...

Phase 2 filing on track for Q1 2025 "The acceptance of our third U.S. IND is an important milestone for Aligos,” said ...

CAM2029 is a novel depot formulation of octreotide, a somatostatin analogue, administered subcutaneously once monthly.

Global Cancer Antibody Drug Conjugates Market: 2020 - 2030 Global Cancer Antibody Drug Conjugates Market Opportunity > US$ 50 ...

NanoViricides, Inc. (NYSE Amer.: NNVC ) (the “Company”), a clinical stage global leader in broad-spectrum antiviral ...

The FDA has given clearance to Adcentrx Therapeutics’ IND application for an antibody-drug conjugate (ADC) targeting solid ...

FDA published a JAMA article on October 15, 2024, describing several areas of focus for regulation of AI used in the medical products. The JAMA article follows a June 2024 FDA blog post by Troy Tazbaz ...

Thermo Fisher’s John Lesica discusses how mass spectrometry technology enables scientific breakthroughs in genomics and ...